-
ATA is Founded!
ATA is founded in 1923 and continues to thrive! -
American Thyroid Association Receives Top Honor for Health Information on Its Web Site
(FALLS CHURCH, VA)—The American Thyroid Association (ATA) is the recipient of the 2004 Aesculapius Award — given by the nonprofit Health Improvement Institute (HII) to promote excellence in health communications — for its web site, www.thyroid.org. -
ATA Advisory supports public health recommendations by Japanese government
The media has reported that drinking water supplies in Tokyo following the nuclear accident at the Fukushima Daiichi plant have contained up to 210 becquerels of radioactive iodine (I-131) per liter. -
New Impact Factor for Thyroid is 4.327, a 66% increase!
New Impact Factor *4.327! Editor-in-Chief: Charles H. Emerson, MD We are pleased to announce the 2010 Impact Factor for Thyroid is 4.327, a 66% increase from last year. -
FDA approves sorafenib for thyroid carcinoma
From the American Thyroid Association: In collaboration with the Food and Drug Administration (FDA), and as a service to our members, ATA will provide updates on recent FDA approvals and other important FDA actions (e.g., updated safety information, new prescribing information) pertaining to therapies for cancer patients. -
New Hypothyroidism Treatment Guidelines from American Thyroid Association Published in Thyroid Journal
New Rochelle, NY, September 30, 2014—Levothyroxine (L-T4), long the standard of care for treating hypothyroidism, is effective in most patients, but some individuals do not regain optimal health on L-T4 monotherapy -
Christmas Eve Discovery 100 Years Ago is Still Helping Millions
From Mayo Clinic – Some medical discoveries truly stand the test of time. The case of a dedicated Mayo Clinic chemist is a prime example. Feeling he was on the verge of a breakthrough that could help countless people, Edward Kendall spent Christmas Eve 1914 locked away in his lab. -
Public Comment on Draft Research Plan: Screening for Thyroid Cancer
From: Agency for Healthcare Research and Quality (AHRQ)The U.S. Preventive Services Task Force posted today a draft research plan on screening for thyroid cancer -
FDA approves lenvatinib for metastatic thyroid cancer
From the American Thyroid Association: In collaboration with the Food and Drug Administration (FDA), and as a service to our members, ATA will provide updates on recent FDA approvals and other important FDA actions (e.g., updated safety information, new prescribing information) pertaining to therapies for cancer patients. -
ATA 2015 Call for Abstract Submissions
Regular Call Abstract Submission: Site Opens – Wednesday, April 8, 2015 Site Closes – Wednesday, June 17, 2015 Abstract Submission Site Now Live
